Macular Degeneration Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People aged 50 or older, of any gender
- People diagnosed with intermediate age-related macular degeneration (AMD), specifically classified as AREDS Grade 3
- People where both eyes meet the study's requirements
- People willing to sign a consent form, follow the study's procedures, and attend all follow-up appointments
- People who are able to keep their dietary supplements and lifestyle habits as consistent as possible throughout the study
Who may not be able to join:
- People with severe short-sightedness (above a certain level, measured as greater than 8 diopters)
- People whose pupils do not open wide enough, even with dilating eye drops (confirm with trial site)
- People who are expected to need eye surgery during the study period
- People with a significant cataract affecting vision
- People who have had eye surgery within the past 6 months
- People who have previously had retinal treatments, including anti-VEGF injections or laser treatment to the retina
- People with diabetic retinopathy (damage to the retina caused by diabetes)
- People with other retinal or macular conditions, such as retinitis pigmentosa, diabetic macular oedema, retinal scarring, or blocked retinal blood vessels
- People with other eye conditions such as a lazy eye, uncontrolled eye pressure, uncontrolled glaucoma, significant cataract, or certain structural problems affecting the retina
- People with certain other health conditions or factors that the trial doctor considers may interfere with the study
- People who are pregnant or breastfeeding
- People already taking part in another clinical intervention study
- People not expected to be able to complete the trial due to mental health, age, or other personal circumstances
- People with a sensitivity to light
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Mario Romano, Prof., Director Department of Ophthalmology and Operational Unit, Full professor - Humanitas Gavazzeni
Phone: +39 02 8224 2555
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Absence of autofluorescence (FAF) laser-light spot; Absence of NIR-cSLO laser-light spot traces; Treatment-Emergent Adverse Events (TEAE)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.